Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Votubia
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Votubia 10mg tablets
0801050AXBCACAB
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 2.5mg tablets
0801050AXBCABAC
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 2mg dispersible tablets
0801050AXBCADAG
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 3mg dispersible tablets
0801050AXBCAEAH
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 5mg dispersible tablets
0801050AXBCAFAI
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 5mg tablets
0801050AXBCAAAA
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.